POV: You feel a sharp pain in your chest after all the years of caffeine abuse

A new study in The New England Journal of Medicine shows that cabozantinib can significantly slow disease progression in people with advanced neuroendocrine tumors who have already had treatment. This could be a game-changer for patients looking for more options.

Read more here: nej.md/3AYuEoI

When the nurse says they checked everywhere for the med, but you walk up, open the drawer, and there it is—chilling like it’s waiting for you to personally escort it.

Me checking if my heart can handle another headline in 2024… diagnosis not looking good.

Why is long-term weight loss so challenging?

New research in Nature reveals a key factor: the epigenetic memory of fat cells.

Interesting read about the biological hurdles to sustainable weight management.

Read more: www.nature.com/articles/s41...